Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled TrialVedang Murthy, Umesh Mahantshetty, Priyamvada Maitre et al.|Journal of Clinical Oncology|2021Cited by 338
Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trialVedang Murthy, Umesh Mahantshetty, Ganesh Bakshi et al.|Radiotherapy and Oncology|2020Cited by 70
Early Results of Extreme Hypofractionation Using Stereotactic Body Radiation Therapy for High-risk, Very High-risk and Node-positive Prostate CancerVedang Murthy, Ganesh Bakshi, Gargee Mulye et al.|Clinical Oncology|2018Cited by 47
Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective StudyVedang Murthy, Shyam Kishore Shrivastava, Renuka Masodkar et al.|International Journal of Radiation Oncology*Biology*Physics|2015Cited by 40
Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose EscalationVedang Murthy, Ganesh Bakshi, Mahendra Pal et al.|Clinical Oncology|2019Cited by 31